METODO DI BELLA > INDICE DELLA DOCUMENTAZIONE > Area Pazienti - Documentazione

 
 
Area Pazienti - Documentazione
 
 
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. (12/04/2011)
Dettaglio
Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer. (12/04/2011)
Dettaglio
Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells. (12/04/2011)
Dettaglio
Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice. (12/04/2011)
Dettaglio
Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course. (12/04/2011)
Dettaglio
All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. (12/04/2011)
Dettaglio
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. (12/04/2011)
Dettaglio
In vivo functional and anatomic imaging for assessment of in vivo gene transfer. (12/04/2011)
Dettaglio
SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. (12/04/2011)
Dettaglio
Laryngeal paragangliomas - controversies in diagnosis and management. (12/04/2011)
Dettaglio
Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2. (12/04/2011)
Dettaglio
Value of 123I-MIBG Scintigraphy in Paraganglioma. (12/04/2011)
Dettaglio
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG3899. (12/04/2011)
Dettaglio
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study. (12/04/2011)
Dettaglio
Vitamins and prostate cancer risk. (12/04/2011)
Dettaglio
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |
 
 

Stampa